[Congressional Record Volume 167, Number 20 (Wednesday, February 3, 2021)]
[Senate]
[Page S368]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 287. Mr. BRAUN submitted an amendment intended to be proposed by 
him to the concurrent resolution S. Con. Res. 5, setting forth the 
congressional budget for the United States Government for fiscal year 
2021 and setting forth the appropriate budgetary levels for fiscal 
years 2022 through 2030; which was ordered to lie on the table; as 
follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO 
                   ESTABLISHING TRANSPARENCY AROUND PHARMACY 
                   BENEFIT MANAGERS AND PROHIBITING ANTI-
                   COMPETITIVE PHARMACY BENEFIT MANAGER PRACTICES.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to 
     establishing transparency around pharmacy benefit managers 
     and prohibiting anti-competitive pharmacy benefit manager 
     practices with respect to Medicare part D, by the amounts 
     provided in such legislation for those purposes, provided 
     that such legislation would not increase the deficit over 
     either the period of the total of fiscal years 2021 through 
     2025 or the period of the total of fiscal years 2021 through 
     2030.
                                 ______